FO
TTPH

FT Options’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

FT Options’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$82K Buy
+600
New +$80.3K 0.12% 110
2016
Q2 		– Sell
-94
Closed -$9K – 427
2016
Q1 		$9K Buy
+94
New +$9.39K 0.01% 248

Other funds holding TTPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

FT Options's TTPH Position: Q3 2017 in Review

FT Options opened a new position in Tetraphase Pharmaceuticals, Inc. (TTPH) in Q3 2017: 600 shares worth $82K. The stake represents 0.12% of the portfolio and ranks #110 among its holdings. This is a return to the name: FT Options previously reported a position in TTPH as recently as Q1 2016.

FT Options first reported a position in TTPH in Q1 2016 and has held it in 2 quarters since. 94 funds tracked by Wall St. Rank hold TTPH as of Q3 2017.

  • FT Options held 600 shares of Tetraphase Pharmaceuticals, Inc. worth $82K as of Q3 2017.
  • Tetraphase Pharmaceuticals, Inc. was a new FT Options position in Q3 2017.
  • Tetraphase Pharmaceuticals, Inc. made up 0.12% of FT Options's portfolio in Q3 2017, its #110 holding.
  • FT Options first reported a position in Tetraphase Pharmaceuticals, Inc. in Q1 2016 and has held it in 2 quarters since.
  • 94 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q3 2017.

Based on FT Options's 13F filing for Q3 2017, filed 13 Nov 2017.